Editas Medicine

EDIT

Market cap $457M

EDIT Hedge Fund Activity: Q1 2026 in Review

207 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2026, worth a combined $128M — up 24% from $102M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new EDIT positions and 23 closed out — a net gain of 15 holders — while 58 added to existing stakes and 50 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $4.08M. The largest seller was Jane Street, cutting an estimated $2.21M.

• 207 institutional investors held Editas Medicine (EDIT) as of Q1 2026, up from 196 in Q4 2025.
• Funds reported $128M of Editas Medicine stock for Q1 2026, up 24% quarter-over-quarter.
• 38 funds opened new Editas Medicine positions in Q1 2026 and 23 closed out, a net change of +15 holders.
• The largest Editas Medicine buyer in Q1 2026 was Opaleye Management, an estimated $4.08M added.
• The largest Editas Medicine seller in Q1 2026 was Jane Street, an estimated $2.21M sold.

Based on aggregated 13F filings for Q1 2026.